MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Adenoid Cystic Carcinoma

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: September 1, 2020
Study on the Treatment of Refractory and Locally Advanced Head and Neck Malignant Tumor With Anlotinib Hydrochloride Capsules Combined With Chemoradiotherapy
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 64
  • Start Date: June 2, 2020
A Phase II Study of Lenvatinib Plus Pembrolizumab in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma and Other Salivary Gland Cancers
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: June 2020
A Prospective, Open-label, Randomized Controlled Clinical Study to Evaluate the Efficacy and Safety of All-trans Retinoic Acid (ATRA) in the Treatment of Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 10
  • Start Date: May 26, 2020
Lutetium-177-PSMA Radioligand Therapy for Advanced Salivary Gland Cancer, a Phase II Pilot Study.
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 72
  • Start Date: March 4, 2020
A Phase 2 Open-Label, Multicenter, Study to Evaluate the Efficacy and Safety of Rivoceranib in Subjects With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) of All Anatomic Sites of Origin
Clinical Trial
Radiation
  • Status: Recruiting
  • Study Type: Radiation
  • Participants: 314
  • Start Date: December 15, 2019
Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: July 22, 2019
A Phase 2 Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma (ACC)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 87
  • Start Date: December 14, 2018
A Phase 2, Open-Label, Multi-center Study of AL101 in Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 25
  • Start Date: September 5, 2018
The Efficacy of Cabozantinib in Advanced SAlivary Gland Cancer Patients, a Phase II Clinical Trial
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 54
  • Start Date: June 8, 2018
An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects With Solid Tumors or Lymphoma
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 22
  • Start Date: June 6, 2018
Chidamide Combined With Cisplatin in Recurrent or Metastatic Head and Neck Adenoid Cystic Carcinoma: A Prospective, Open-label, Phase II Study of a Single Center
Clinical Trial
Radiation
  • Status: Recruiting
  • Study Type: Radiation
  • Participants: 250
  • Start Date: December 23, 2017
Transnational Randomized Study Comparing Carbon Ions Therapy Versus Conventional Radiotherapy - Including Protontherapy - for the Treatment of Radioresistant Tumors
Showing 1–12 of 26 Clinical Trials
Next